Skip to main content
Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.34
+0.50 (7.31%)
At close: Mar 9, 2026, 4:00 PM EDT
7.34
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Kyntra Bio Revenue

Kyntra Bio had revenue of $1.08M in the quarter ending September 30, 2025, with 774.80% growth. This brings the company's revenue in the last twelve months to $8.30M, down -117.53% year-over-year. In the year 2024, Kyntra Bio had annual revenue of $29.62M, down -36.71%.

Revenue (ttm)
$8.30M
Revenue Growth
-117.53%
P/S Ratio
3.33
Revenue / Employee
$36,880
Employees
225
Market Cap
29.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evaxion 7.53M
Cue Biopharma 7.10M
Dyadic International 3.34M
IGC Pharma 1.11M
RenovoRx 928.00K
Exicure 500.00K
Hyperion DeFi 345.32K
Revenue Rankings

KYNB News

More News